Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.
Saved in:
| Title: | Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro. |
|---|---|
| Authors: | Santos IA; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom., Grosche VR; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.; Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, São Jose do Rio Preto, Brazil., Cassani NM; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom., Veneziani RCS; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil., Ribeiro GL; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil., Bastos JK; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Nicolau-Junior N; Institute of Biotechnology, Federal University of Uberlândia (UFU), Uberlândia, Brazil., Merits A; Institute of Bioengineering, University of Tartu, Tartu, Estonia., Martins CHG; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil., Harris M; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom., Jardim ACG; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom. |
| Source: | Frontiers in microbiology [Front Microbiol] 2025 May 09; Vol. 16, pp. 1540934. Date of Electronic Publication: 2025 May 09 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40415937 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Santos+IA%22">Santos IA</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Grosche+VR%22">Grosche VR</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.; Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, São Jose do Rio Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Cassani+NM%22">Cassani NM</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Veneziani+RCS%22">Veneziani RCS</searchLink>; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil.<br /><searchLink fieldCode="AU" term="%22Ribeiro+GL%22">Ribeiro GL</searchLink>; Nucleus of Research in Sciences and Technology, University of Franca, Franca, Brazil.<br /><searchLink fieldCode="AU" term="%22Bastos+JK%22">Bastos JK</searchLink>; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Nicolau-Junior+N%22">Nicolau-Junior N</searchLink>; Institute of Biotechnology, Federal University of Uberlândia (UFU), Uberlândia, Brazil.<br /><searchLink fieldCode="AU" term="%22Merits+A%22">Merits A</searchLink>; Institute of Bioengineering, University of Tartu, Tartu, Estonia.<br /><searchLink fieldCode="AU" term="%22Martins+CHG%22">Martins CHG</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.<br /><searchLink fieldCode="AU" term="%22Harris+M%22">Harris M</searchLink>; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jardim+ACG%22">Jardim ACG</searchLink>; Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.; Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548977%22">Frontiers in microbiology</searchLink> [Front Microbiol] 2025 May 09; Vol. 16, pp. 1540934. <i>Date of Electronic Publication: </i>2025 May 09 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548977 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-302X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221664302X%22">1664302X </searchLink><i>NLM ISO Abbreviation: </i>Front Microbiol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40415937 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmicb.2025.1540934 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1540934 Titles: – TitleFull: Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Santos IA – PersonEntity: Name: NameFull: Grosche VR – PersonEntity: Name: NameFull: Cassani NM – PersonEntity: Name: NameFull: Veneziani RCS – PersonEntity: Name: NameFull: Ribeiro GL – PersonEntity: Name: NameFull: Bastos JK – PersonEntity: Name: NameFull: Nicolau-Junior N – PersonEntity: Name: NameFull: Merits A – PersonEntity: Name: NameFull: Martins CHG – PersonEntity: Name: NameFull: Harris M – PersonEntity: Name: NameFull: Jardim ACG IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 05 Text: 2025 May 09 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1664-302X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in microbiology Type: main |
| ResultId | 1 |